Sex ratio in two peer-reviewed mRNA vaccine/myocarditis case series
Males with (at least) seven times more cases of myocarditis than females
The question of mRNA vaccine myocarditis and age/sex ratio skew has been plainly evident since the earliest reports from Israel in March 2021. This is a major issue for young males.
In this post, I will look at a two key studies that were previously reviewed in this substack, only this time the focus will be on their sex ratio data.
The CDC study on mRNA vaccine myocarditis recovery reviewed 519 patients with myocarditis, aged 12 to 29. The sex ratio was 88% male, 12% female - a 7:1 ratio.
The Mansanguan study which evaluated cardiac function before and after the second Pfizer shot in 301 Thai youths aged 12 to 17, demonstrated a seven to zero male:female sex ratio for myocarditis post-injection:
Unfortunately, Mansanguan does not break down results for ECG abnormalities by sex.
SUMMARY:
These two large and important mRNA vaccine/myocarditis peer-reviewed articles show a sex ratio of 7:1 male to female, or higher. It is very clear that male sex is a significant risk factor for myocarditis.
Within North America, this has only been recognized by the State of Florida. No medical associations have issued alerts for young males, to my knowledge. This is long overdue.
It's at the point that the authorities know, but don't want to acknowledge the harms of these vaccines. It baffles me that anybody on earth can think these injections are safe, but it does show how low info and low desire to obtain info about something so important is to the average person.